182 related articles for article (PubMed ID: 35116104)
1. Targeting BET bromodomain proteins in solid tumors.
Sahai V; Redig AJ; Collier KA; Eckerdt FD; Munshi HG
Oncotarget; 2016 Aug; 7(33):53997-54009. PubMed ID: 27283767
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer.
Hashimoto M; Masuda T; Nakano Y; Tobo T; Saito H; Koike K; Takahashi J; Abe T; Ando Y; Ozato Y; Hosoda K; Higuchi S; Hisamatsu Y; Toshima T; Yonemura Y; Hata T; Uemura M; Eguchi H; Doki Y; Mori M; Mimori K
Cancer Sci; 2024 Mar; ():. PubMed ID: 38494600
[TBL] [Abstract][Full Text] [Related]
3. Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders.
Dhulkifle H; Diab MI; Algonaiah M; Korashy HM; Maayah ZH
ACS Pharmacol Transl Sci; 2024 Mar; 7(3):546-559. PubMed ID: 38481679
[TBL] [Abstract][Full Text] [Related]
4. Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8.
Wu T; Chen Y; You Q; Jiang Z; Chen X
Eur J Med Chem; 2024 Mar; 268():116271. PubMed ID: 38401187
[TBL] [Abstract][Full Text] [Related]
5. BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.
Nicholas DA; Andrieu G; Strissel KJ; Nikolajczyk BS; Denis GV
Cell Mol Life Sci; 2017 Jan; 74(2):231-243. PubMed ID: 27491296
[TBL] [Abstract][Full Text] [Related]
6. Orchestrating epigenetic readers: Progress in understanding the functions of bromodomain-containing protein 4 complexes.
Brasier AR
Mol Ther Nucleic Acids; 2023 Jun; 32():340-342. PubMed ID: 37128276
[No Abstract] [Full Text] [Related]
7. BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes.
Ma L; Wang J; Zhang Y; Fang F; Ling J; Chu X; Zhang Z; Tao Y; Li X; Tian Y; Li Z; Sang X; Zhang K; Lu L; Wan X; Chen Y; Yu J; Zhuo R; Wu S; Lu J; Pan J; Hu S
Cancer Biol Ther; 2022 Dec; 23(1):1-15. PubMed ID: 36170346
[TBL] [Abstract][Full Text] [Related]
8. BRD4 and MYC: power couple in transcription and disease.
Kotekar A; Singh AK; Devaiah BN
FEBS J; 2023 Oct; 290(20):4820-4842. PubMed ID: 35866356
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer.
Kundu M; Butti R; Panda VK; Malhotra D; Das S; Mitra T; Kapse P; Gosavi SW; Kundu GC
Mol Cancer; 2024 May; 23(1):92. PubMed ID: 38715072
[TBL] [Abstract][Full Text] [Related]
10. Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor.
Hung YH; Wang HC; Pan MR; Chen LT
J Pers Med; 2024 Feb; 14(3):. PubMed ID: 38540967
[TBL] [Abstract][Full Text] [Related]
11. ABBV-744 induces autophagy in gastric cancer cells by regulating PI3K/AKT/mTOR/p70S6k and MAPK signaling pathways.
Wang K; Tang J; Fan S; Su H; Yu R; Zhang Y; Wu H; Lv Y; Zhang S; Zou X
Neoplasia; 2023 Nov; 45():100936. PubMed ID: 37769529
[TBL] [Abstract][Full Text] [Related]
12. BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression.
Zeng F; Li Y; Meng Y; Sun H; He Y; Yin M; Chen X; Deng G
Exp Mol Med; 2023 Feb; 55(2):364-376. PubMed ID: 36720918
[TBL] [Abstract][Full Text] [Related]
13. Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma.
Vieito M; Simonelli M; de Vos F; Moreno V; Geurts M; Lorenzi E; Macchini M; van den Bent MJ; Del Conte G; de Jonge M; Martín-Soberón MC; Amoroso B; Sanchez-Perez T; Zuraek M; Hanna B; Aronchik I; Filvaroff E; Chang H; Mendez C; Arias Parro M; Wei X; Nikolova Z; Sepulveda JM
Neurooncol Adv; 2022; 4(1):vdac146. PubMed ID: 36382109
[TBL] [Abstract][Full Text] [Related]
14. Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers.
Sun HY; Du ST; Li YY; Deng GT; Zeng FR
World J Gastrointest Oncol; 2022 Jan; 14(1):75-89. PubMed ID: 35116104
[TBL] [Abstract][Full Text] [Related]
15. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
Taniguchi Y
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
[TBL] [Abstract][Full Text] [Related]
16. BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications.
To KKW; Xing E; Larue RC; Li PK
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049806
[TBL] [Abstract][Full Text] [Related]
17. The Functions of BET Proteins in Gene Transcription of Biology and Diseases.
Cheung KL; Kim C; Zhou MM
Front Mol Biosci; 2021; 8():728777. PubMed ID: 34540900
[TBL] [Abstract][Full Text] [Related]
18. BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell.
Deeney JT; Belkina AC; Shirihai OS; Corkey BE; Denis GV
PLoS One; 2016; 11(3):e0151329. PubMed ID: 27008626
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
